{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T22:12:32Z","timestamp":1783462352636,"version":"3.55.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"MeMed Diagnostics Ltd"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Community-acquired pneumonia (CAP) remains a leading cause of hospital admissions and mortality. A novel host-response test, MeMed BV (MMBV), has been developed for discriminating between bacterial and viral infection that could improve the clinical management of CAP.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To evaluate the cost-effectiveness of using MMBV to guide antibiotic decisions in the clinical management of CAP in the UK.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>An economic model was developed to understand the incremental cost per person associated with the implementation of MMBV from the UK NHS perspective. A qualitative care pathway analysis was performed to inform the standard of care (SOC) and SOC plus MMBV (SOC\u200a+\u200aMMBV) clinical pathways captured in the model.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In the base case analysis, the SOC + MMBV strategy for a hypothetical cohort of 1000 patients (adults and children modelled independently) presenting to the emergency department with suspected CAP was estimated to provide total cost savings of \u00a3134\u200a018 and \u00a3105\u200a750 for adults and children, respectively. Cost savings were associated with reductions in total antibiotic treatment, the number of patients receiving additional diagnostic tests, and hospital admissions. Deterministic sensitivity analysis revealed that the specificity of SOC + MMBV and sensitivity of the SOC were primary drivers of the cost model for adults, whereas the specificity of SOC and SOC + MMBV were primary drivers for paediatrics.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Overall, the model predicts that the introduction of SOC\u200a+\u200aMMBV has the potential to be cost-saving and promote antimicrobial stewardship for both adult and paediatric CAP patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jacamr\/dlaf016","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T20:32:17Z","timestamp":1738269137000},"source":"Crossref","is-referenced-by-count":5,"title":["Host-response testing with MeMed BV in community-acquired pneumonia: an economic evaluation from the UK NHS perspective"],"prefix":"10.1093","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2969-793X","authenticated-orcid":false,"given":"Emily","family":"Gregg","sequence":"first","affiliation":[{"name":"York Health Economics Consortium (YHEC), University of York , York ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Graziadio","sequence":"additional","affiliation":[{"name":"York Health Economics Consortium (YHEC), University of York , York ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Green","sequence":"additional","affiliation":[{"name":"York Health Economics Consortium (YHEC), University of York , York ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0389-7912","authenticated-orcid":false,"given":"Daniela","family":"Afonso","sequence":"additional","affiliation":[{"name":"York Health Economics Consortium (YHEC), University of York , York ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5802-3198","authenticated-orcid":false,"given":"Monica","family":"Garrett","sequence":"additional","affiliation":[{"name":"York Health Economics Consortium (YHEC), University of York , York ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Watts","sequence":"additional","affiliation":[{"name":"York Health Economics Consortium (YHEC), University of York , York ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Watkins","sequence":"additional","affiliation":[{"name":"York Health Economics Consortium (YHEC), University of York , York ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enitan D","family":"Carrol","sequence":"additional","affiliation":[{"name":"Department of Clinical Infection, Microbiology and Immunology, University of Liverpool Institute of Infection, Veterinary and Ecological Sciences , Liverpool ,","place":["UK"]},{"name":"Department of Paediatric Infectious Diseases and Immunology, Alder Hey Children\u2019s NHS Foundation Trust , Liverpool ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Cooke","sequence":"additional","affiliation":[{"name":"NIHR London In Vitro Diagnostics Co-operative, Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine , Imperial College, London ,","place":["UK"]},{"name":"Manchester Pharmacy School, Faculty of Biology, Medicine and Health , University of Manchester, Manchester ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Felton","sequence":"additional","affiliation":[{"name":"Division of Immunology, Immunity to Infection and Respiratory Medicine, Faculty of Biology, Medicine and Health, University of Manchester , Manchester ,","place":["UK"]},{"name":"Wythenshawe Hospital, Manchester University NHS Foundation Trust , Manchester ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,2,19]]},"reference":[{"key":"2025022008185647300_dlaf016-B1","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis","volume":"399","author":"Li","year":"2022","journal-title":"Lancet"},{"key":"2025022008185647300_dlaf016-B2","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/S1473-3099(24)00176-2","article-title":"Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990\u20132021: a systematic analysis from the Global Burden of Disease Study 2021","volume":"24","author":"GBD 2021 Lower Respiratory Infections and Antimicrobial Resistance Collaborators","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2025022008185647300_dlaf016-B3","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1001\/jamainternmed.2021.0269","article-title":"Accuracy of practitioner estimates of probability of diagnosis before and after testing","volume":"181","author":"Morgan","year":"2021","journal-title":"JAMA Intern Med"},{"key":"2025022008185647300_dlaf016-B4","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1056\/NEJMoa1405870","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. children","volume":"372","author":"Jain","year":"2015","journal-title":"N Engl J Med"},{"key":"2025022008185647300_dlaf016-B5","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1056\/NEJMoa1500245","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. adults","volume":"373","author":"Jain","year":"2015","journal-title":"N Engl J Med"},{"key":"2025022008185647300_dlaf016-B6","doi-asserted-by":"publisher","first-page":"00286-2022","DOI":"10.1183\/23120541.00286-2022","article-title":"Pathogen spectra in hospitalised and nonhospitalised children with community-acquired pneumonia","volume":"9","author":"Wetzke","year":"2023","journal-title":"ERJ Open Res"},{"key":"2025022008185647300_dlaf016-B7","author":"National Institute for Health and Care Excellence (NICE)"},{"key":"2025022008185647300_dlaf016-B8","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2025022008185647300_dlaf016-B9","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1001\/jamainternmed.2024.0037","article-title":"Clinical outcomes of rapid respiratory virus testing in emergency departments: a systematic review and meta-analysis","volume":"184","author":"Schober","year":"2024","journal-title":"JAMA Intern Med"},{"key":"2025022008185647300_dlaf016-B10","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.jinf.2023.03.005","article-title":"Rapid multiplex PCR for respiratory viruses reduces time to result and improves clinical care: results of a systematic review and meta-analysis","volume":"86","author":"Clark","year":"2023","journal-title":"J Infect"},{"key":"2025022008185647300_dlaf016-B11","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1093\/infdis\/jit190","article-title":"Bacterial complications of respiratory viral illness: a comprehensive evaluation","volume":"208","author":"Falsey","year":"2013","journal-title":"J Infect Dis"},{"key":"2025022008185647300_dlaf016-B12","author":"National Institute for Health and Care Excellence (NICE)"},{"key":"2025022008185647300_dlaf016-B13","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.cmi.2024.05.014","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for antimicrobial stewardship in emergency departments (endorsed by European Association of Hospital Pharmacists)","volume":"30","author":"Schoffelen","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"2025022008185647300_dlaf016-B14","doi-asserted-by":"publisher","first-page":"e0120012","DOI":"10.1371\/journal.pone.0120012","article-title":"A novel host-proteome signature for distinguishing between acute bacterial and viral infections","volume":"10","author":"Oved","year":"2015","journal-title":"PLoS One"},{"key":"2025022008185647300_dlaf016-B15","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.cmi.2021.10.019","article-title":"A host signature based on TRAIL, IP-10, and CRP for reducing antibiotic overuse in children by differentiating bacterial from viral infections: a prospective, multicentre cohort study","volume":"28","author":"Papan","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"2025022008185647300_dlaf016-B16","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.cmi.2023.05.033","article-title":"Host test based on tumor necrosis factor-related apoptosis-inducing ligand, interferon gamma-induced protein-10 and C-reactive protein for differentiating bacterial and viral respiratory tract infections in adults: diagnostic accuracy study","volume":"29","author":"Halabi","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"2025022008185647300_dlaf016-B17","doi-asserted-by":"publisher","first-page":"e13167","DOI":"10.1002\/emp2.13167","article-title":"A rapid host-protein test for differentiating bacterial from viral infection: Apollo diagnostic accuracy study","volume":"5","author":"Bachur","year":"2024","journal-title":"J Am Coll Emerg Physicians Open"},{"key":"2025022008185647300_dlaf016-B18","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae656","article-title":"Development of a reference standard to assign bacterial versus viral infection etiology using an all-inclusive methodology for comparison of novel diagnostic tool performance","author":"Allen","year":"2025.","journal-title":"Clin Infect Dis"},{"key":"2025022008185647300_dlaf016-B19","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.jval.2024.02.003","article-title":"Is the comparator in your diagnostic cost-effectiveness model \u201cstandard of care\u201d? Recommendations from literature reviews and expert interviews on how to identify and operationalize it","volume":"27","author":"Graziadio","year":"2024","journal-title":"Value Health"},{"key":"2025022008185647300_dlaf016-B20","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1016\/j.jval.2023.08.014","article-title":"Care pathway analysis to inform the earliest stages of technology development: scoping oncological indications in need of innovation","volume":"26","author":"Scholte","year":"2023","journal-title":"Value Health"},{"key":"2025022008185647300_dlaf016-B21","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3390\/mi11030291","article-title":"How to ease the pain of taking a diagnostic point of care test to the market: a framework for evidence development","volume":"11","author":"Graziadio","year":"2020","journal-title":"Micromachines"},{"key":"2025022008185647300_dlaf016-B22","author":"National Institute for Health and Care Excellence (NICE)"},{"key":"2025022008185647300_dlaf016-B23","doi-asserted-by":"publisher","first-page":"dlab029","DOI":"10.1093\/jacamr\/dlab029","article-title":"Paediatric common infections pathways: improving antimicrobial stewardship and promoting ambulation for children presenting with common infections to hospitals in the UK and Ireland","volume":"3","author":"Horner","year":"2021","journal-title":"JAC Antimicrob Resist"},{"key":"2025022008185647300_dlaf016-B24","author":"National Institute for Health and Care Excellence (NICE)"},{"key":"2025022008185647300_dlaf016-B25","doi-asserted-by":"publisher","first-page":"e765","DOI":"10.3399\/bjgp18X699545","article-title":"Diagnosis and treatment of community-acquired pneumonia in patients with acute cough: a quantitative study of decision thresholds in primary care","volume":"68","author":"Ebell","year":"2018","journal-title":"Br J Gen Pract"},{"key":"2025022008185647300_dlaf016-B26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S1473-3099(17)30592-3","article-title":"Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis","volume":"18","author":"Schuetz","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2025022008185647300_dlaf016-B27","author":"National Health Service (NHS) England"},{"key":"2025022008185647300_dlaf016-B28","author":"National Institute for Health and Care Research (NIHR)"},{"key":"2025022008185647300_dlaf016-B29","author":"Department of Health and Social Care"},{"key":"2025022008185647300_dlaf016-B30","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1080\/13696998.2022.2090734","article-title":"Hospitalization costs of adult community-acquired pneumonia in England","volume":"25","author":"Campling","year":"2022","journal-title":"J Med Econ"},{"key":"2025022008185647300_dlaf016-B31","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12916-019-1275-z","article-title":"The cost of diagnostic uncertainty: a prospective economic analysis of febrile children attending an NHS emergency department","volume":"17","author":"Leigh","year":"2019","journal-title":"BMC Med"},{"key":"2025022008185647300_dlaf016-B32","author":"National Health Service (NHS) England"},{"key":"2025022008185647300_dlaf016-B33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12916-021-02204-0","article-title":"Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations","volume":"20","author":"Husereau","year":"2022","journal-title":"BMC Med"},{"key":"2025022008185647300_dlaf016-B34","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1080\/13696998.2022.2026686","article-title":"Cost impact analysis of novel host-response diagnostic for patients with community-acquired pneumonia in the emergency department","volume":"25","author":"Schneider","year":"2022","journal-title":"J Med Econ"},{"key":"2025022008185647300_dlaf016-B35","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.3390\/ijerph20053853","article-title":"Cost-impact analysis of a novel diagnostic test to assess community-acquired pneumonia etiology in the emergency department setting: a multi-country European study","volume":"20","author":"Houshmand","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"2025022008185647300_dlaf016-B36","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jamainternmed.2024.0077","article-title":"Inappropriate diagnosis of pneumonia among hospitalized adults","volume":"184","author":"Gupta","year":"2024","journal-title":"JAMA Intern Med"}],"container-title":["JAC-Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jacamr\/article-pdf\/7\/1\/dlaf016\/61969615\/dlaf016.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jacamr\/article-pdf\/7\/1\/dlaf016\/61969615\/dlaf016.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T08:21:08Z","timestamp":1740039668000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jacamr\/article\/doi\/10.1093\/jacamr\/dlaf016\/8023371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,26]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12,26]]}},"URL":"https:\/\/doi.org\/10.1093\/jacamr\/dlaf016","relation":{},"ISSN":["2632-1823"],"issn-type":[{"value":"2632-1823","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2024,12,26]]},"article-number":"dlaf016"}}